Avendus’s Healthcare practice leverages deep domain knowledge of pharma industry, healthcare providers and services, significant transaction and operating experience to provide strategic and corporate finance advice to a wide range of clients including growing businesses, large corporate houses and private equity funds. The group’s philosophy on every transaction revolves around senior team attention, hands-on approach and independent advice delivering best-in-class solutions to clients.
Sub-Sectors in Focus
Our mergers and acquisitions (M&A) advisory and private equity (PE) syndication services are recognized as amongst the best in these chosen sub-sectors.
- Pharmaceuticals - generics/specialty generics, specialty pharmaceuticals, API / CDMO / CRO
- Healthcare delivery - hospitals, diagnostics, single specialty
- Medical technology - lifesciences, medical devices, consumables
Led By
Chintan Kothari
Executive Director and Head, Healthcare, Avendus Capital
Chintan Kothari leads the Healthcare vertical for Avendus's investment banking business and is based in Mumbai.
He has an overall 15 years of experience in investment banking where he led healthcare and consumer vertical for Citigroup and prior to that for Rothschild India. Chintan has extensive transaction experience aggregating over USD 10 billion across pharmaceuticals (generics, injectables, branded generics, API and animal health) and healthcare sub-sectors (hospitals, diagnostics and single specialty). This covers a broad spectrum of transactions including both private and public markets. He has advised several large corporates including Pfizer, Sun Pharma, Lupin, Hindustan Unilever, United Spirits, Apollo Hospitals, Fortis, Dr. Lal Pathlabs, Metropolis as well as multiple mid-market family-owned businesses and several global private equity (PE) funds.
Chintan holds an MBA degree from Case Western Reserve University, USA and a Bachelor of Commerce degree from Sydenham College, Mumbai. He is a CFA charter holder.
Transactions
.jpg){kind=spacer}
Reports
D2C Brands: Disrupting the next decade of shopping
Consumption patterns in India are evolving. With rise in online shopping and spurred by the opportunity to capitalize on white spaces and a more demanding consumer, new-age brands are emerging. Eyeing a $100bn addressable market by 2025, direct-to-customer brands are set to disrupt the way India shops in the coming decade.
Indian Specialty Chemicals Industry - Biggest Beneficiary of the Global Paradigm Shift
Avendus in collaboration with FICCI, has developed this report in order to highlight the emerging opportunity for the Indian Specialty Chemicals industry, which is estimated to double in size by 2025.
Implication of Coronavirus On Technology Outsourcing M&A Deal Activity – Evolving Perspective
The second edition of our Coronavirus thought paper, tracks the pandemic’s impact on the IT outsourcing industry and associated deal activity. Given the strong bounce back in demand and valuation at pre-COVID levels we believe that the market is conducive for deal making.
MuleSoft
MuleSoft, since its acquisition by Salesforce in 2018, has experienced tremendous growth. Industry-wide MuleSoft adoption is expected to continue given that both the API management and the iPaaS (Integration Platform-as-a-Service) industries are experiencing high growth due to increased cloud adoption and connected devices.
ServiceNow
~80% of Fortune 500 companies today use ServiceNow, the leading provider in the IT service management (ITSM) space. With a strong partner network of 1,200+ and growing, the ServiceNow ecosystem is expected to further extend its foothold with global enterprises.
A Perspective on Staffing for IT Services
The staffing industry makes a vital contribution to the economy and provides easy access to jobs. The industry offers opportunities to invest in a fragmented market that is ripe for consolidation. Our report provides insights into a few critical elements which have shaped the IT staffing industry.